CD44 and glioblastoma: Moreover, it was demonstrated that RHAMM enhances the invasiveness of GBM cells, while the expression of CD44 has been correlated with decreased survival in patients as well as the increase of cell proliferation, invasion, and chemoresistance in GBM cells [36–39].